0

A Flow-Cytometry-Based Approach to Facilitate Quantification, Size Estimation and Characterization of Sub-visible Particles in Protein Solutions

Christian Lubich, Mantas Malisauskas, Thomas Prenninger, Thomas Wurz, Peter Matthiessen, Peter L Turecek, Friedrich Scheiflinger, Birgit M Reipert

Pharm Res. 2015 Sep;32(9):2863-76.

PMID: 25788448

Abstract:

Purpose:
Sub-visible particles were shown to facilitate unwanted immunogenicity of protein therapeutics. To understand the root cause of this phenomenon, a comprehensive analysis of these particles is required. We aimed at establishing a flow-cytometry-based technology to analyze the amount, size distribution and nature of sub-visible particles in protein solutions.
Methods:
We adjusted the settings of a BD FACS Canto II by tuning the forward scatter and the side scatter detectors and by using size calibration beads to facilitate the analysis of particles with sizes below 1 μM. We applied a combination of Bis-ANS (4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid dipotassium salt) and DCVJ (9-(2,2-dicyanovinyl)julolidine) to identify specific characteristics of sub-visible particles.
Results:
The FACS technology allows the analysis of particles between 0.75 and 10 μm in size, requiring relatively small sample volumes. Protein containing particles can be distinguished from non-protein particles and cross-β-sheet structures contained in protein particles can be identified.
Conclusions:
The FACS technology provides robust and reproducible results with respect to number, size distribution and specific characteristics of sub-visible particles between 0.75 and 10 μm in size. Our data for number and size distribution of particles is in good agreement with results obtained with the state-of-the-art technology micro-flow imaging.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP58293564 9-(2,2-Dicyanovinyl)julolidine 9-(2,2-Dicyanovinyl)julolidine 58293-56-4 Price
qrcode